Tuesday, July 17, 2018 11:37:04 AM
IMO the only reason they haven't taken this private is for the insulating layer of liability defense a publicly traded corporation can provide. They rode shareholder money to an FDA approval, and to expand initial awareness so they could begin market penetration. Once they began to see revenues come in they began to milk it for all it was worth via pr's, reverse splits, and toxic financing. When they got it to the point that was obvious, and share sales began to dry up, they took it dark.
Now they have set their pay high, and are thus reaping the rewards of a product that should be selling well. I would be willing to bet that nearly all of the money received from product sales is being spent on "director" salary.
I never sold my shares, so I should be receiving the minimum correspondence from the company. We'll see....
Good luck to you, and all others!
**************************************************************
just my opinions, of course!
Never argue with an idiot--they'll just drag you down to their level, and then beat you with experience!
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM